Delivery Order SPE2DB22D3004-SPE2DB25FNE47

Award Date 10/10/24
Potential Completion Date 10/11/24
Potential Value $6.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,667,996 units of Januvia 100 mg tablets, a pharmaceutical product. The contract has a firm fixed price of $12,752.57 and a completion date of September 4, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,891,268 units of the pharmaceutical product Januvia 100 mg tablets. The contract has a firm fixed price of $19,300.14 and a completion date of September 23, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of medical commodities, including...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Januvia 100 mg tablets. The contract has a firm-fixed price of $8,982.23 and an ultimate completion date of August 8, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 and running through December 2025. The...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $1,377.40, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to provide Januvia 100 mg tablets. The contract is a firm fixed price delivery order with no set-aside designation. It is part of a larger indefinite delivery contract (IDC) awarded solely to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $3,474.00 firm-fixed-price contract is for the supply of Januvia 100 mg tablets. The delivery order is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 and running through December 2025. This IDC serves as a primary vehicle...
This is a $16,260.09 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,561,400 units of Januvia 100 mg tablets over a one-year period ending on July 5, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading pharmaceutical distributor, for the supply of Januvia 100 mg tablets. The contract has a ceiling value of $14,326.81 and an ultimate completion date of August 2, 2024. It is a firm-fixed-price type contract with no set-aside used. AmerisourceBergen, through its Corporate Office division, will provide these prescription medications to support military treatment facilities and other...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $16,471.69, is for the delivery of Januvia 100 mg tablets in quantities of 1,000. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,455.28, is for the provision of 4566833359 tablets of the drug JANUVIA 100 MG. The contract has an ultimate completion date of January 6, 2025 and a firm fixed price pricing type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $14,958.15 Firm Fixed Price contract is for the supply of 4,565,631,113 units of the prescription drug Januvia 100 mg tablets. The contract has an ultimate completion date of August 30, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FNE47
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $6,933.64, is for the supply of 4,566,077,815 units of the pharmaceutical product Januvia 100 mg tablets in 90-count packages. The delivery order was issued under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a wide range of medical commodities, including pharmaceuticals, from AmerisourceBergen to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is scheduled for completion on October 11, 2024.

Generated 1/9/25, 9:24 AM